Internal Medicine, Hematology & Oncology · San Antonio, TX
NPI
1487916813
Since 2012
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
5206 Research Dr
San Antonio, TX, 78240
Phone (210) 595-5300
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.9M
198,798 services
Medicare patients, 2024
735
Average age 75
Drug cost, 2024
$4.0M
1,764 prescriptions
Company payments, 2025
$541
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Melissa A Crawley was code J0881 (injection, darbepoetin alfa, 1 microgram (non-esrd use)), 28,095 times for 14 patients. In total Melissa A Crawley billed 198,798 services in 177 codes, and Medicare paid $2.9M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-15.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 28,095 | 14 | $2.33 | $65K |
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 26,010 | 27 | $0.28 | $7,301 |
| J1453 Injection, fosaprepitant, 1 mg | Office | 14,850 | 39 | $0.11 | $1,668 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 14,300 | 12 | $44.75 | $640K |
| J9267 Injection, paclitaxel, 1 mg | Office | 12,911 | 20 | $0.08 | $1,020 |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 9,970 | 21 | $37.09 | $370K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 3,641 | 34 | $0.10 | $381 |
| J9171 Injection, docetaxel, 1 mg | Office | 3,207 | 12 | $0.69 | $2,207 |
| J0897 Injection, denosumab, 1 mg | Office | 2,220 | 13 | $20.58 | $46K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,931 | 61 | $0.09 | $173 |
| 36415 Venipuncture Blood Collection | Office | 1,532 | 482 | $8.65 | $13K |
| 80053 Clinical Chemistry | Office | 1,473 | 481 | $10.32 | $15K |
| 85025 Blood Count | Office | 1,367 | 467 | $7.61 | $10K |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 1,340 | 30 | $0.25 | $339 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,310 | 46 | $0.72 | $941 |
By year: 2022 $2.2M for 135,055 services; 2023 $2.4M for 147,698 services; 2024 $2.9M for 198,798 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,532 | 482 | $8.65 | $13K |
| 80053 Clinical Chemistry | 1,473 | 481 | $10.32 | $15K |
| 85025 Blood Count | 1,367 | 467 | $7.61 | $10K |
| 88185 Surgical Pathology Examination | 691 | 26 | $16.38 | $11K |
| 82784 Immunoassay | 633 | 105 | $9.11 | $5,769 |
| 83615 Clinical Chemistry | 522 | 225 | $5.89 | $3,074 |
| 82728 Clinical Chemistry | 342 | 175 | $13.36 | $4,569 |
| 83540 Clinical Chemistry | 321 | 174 | $6.32 | $2,029 |
| 83550 Clinical Chemistry | 321 | 174 | $8.56 | $2,749 |
| 83521 Immunoassay | 218 | 60 | $16.93 | $3,690 |
Medicare prescription drug claims, 2024
In 2024, the drug Melissa A Crawley prescribed most often to Medicare patients was Anastrozole, with 249 prescriptions and refills. In total Melissa A Crawley wrote 1,764 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 249 | 529 | 62 | $3,810 |
| Eliquis Apixaban | 141 | 243 | 36 | $134K |
| Letrozole Generic | 137 | 302 | 34 | $2,565 |
| Gabapentin Generic | 77 | 97 | 20 | $856 |
| Hydroxyurea Generic | 52 | 97 | 12 | $1,254 |
| Xarelto Rivaroxaban | 50 | 148 | 17 | $78K |
| Dexamethasone Generic | 48 | 54 | 19 | $678 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 47 | 47 | 17 | $1,810 |
| Ondansetron Odt Ondansetron | 43 | 51 | 22 | $804 |
| Escitalopram Oxalate Generic | 32 | 42 | Under 11 | $213 |
| Prochlorperazine Maleate Generic | 31 | 31 | 21 | $904 |
| Morphine Sulfate Er Morphine Sulfate | 29 | 29 | Under 11 | $1,498 |
| Levothyroxine Sodium Generic | 26 | 45 | Under 11 | $226 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 24 | 24 | Under 11 | $172 |
| Mirtazapine Generic | 23 | 39 | Under 11 | $364 |
Brand drugs: - claims; generic drugs: 1,319 claims; opioid claims: 116.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Melissa A Crawley $541 ($541 in general payments such as food, travel and fees) from 9 companies. The largest payer was Gilead Sciences, Inc. with $140.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.